ARWR
Arrowhead Pharmaceuticals Inc
62.40$
-2.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -98.8% | -62,989.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -155.4% | – | -179.5% | – | – | – | |
| – | -91.1% | -11.6% | -6.1% | -53.7% | +157.5% | -99.0% | +82,944.4% | +761.7% | +37.7% | +13.2% | +12.9% | -12.2% | -72.1% | -3.5% | +552.7% | +0.1% | -23.2% | +73.6% | +39.5% | +43.9% | +0.2% | -5.5% | +33.9% | +39.1% | +26.1% | +19.9% | +48.8% | +28.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -46.8% | -3.3% | -9.8% | +23.8% | +270.8% | +79.6% | +13.3% | -31.9% | +7.1% | +46.6% | +250.1% | +76.7% | +57.7% | -35.4% | -5.3% | -14.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -28.6% | +209.7% | +103.7% | +37.6% | -58.3% | -13.4% | +14.6% | +67.8% | +222.3% | +76.7% | +63.5% | -27.8% | – | – | |
| – | +74.3% | -58.1% | -23.7% | +210.2% | +20.2% | -134.2% | – | +984.5% | +204.8% | -97.0% | -674.2% | – | – | – | +3,032.6% | -35.2% | +3,474.4% | -31.9% | +67.8% | -121.1% | – | – | -170.1% | – | -143.0% | – | – | -172.7% | |
| – | – | – | – | -100.0% | – | +26.3% | +31,364.1% | +1.1% | +38.9% | -19.1% | -9.6% | -94.1% | -86.6% | +78.9% | +4,858.8% | -38.1% | +478.5% | +14.7% | +95.9% | +105.1% | -82.1% | +744.4% | -0.4% | +97.2% | +123.9% | +234.9% | -20.0% | -84.0% | |
| – | – | – | – | – | – | +26.3% | +16,903.4% | – | -123.9% | – | -158.8% | – | -34.0% | -136.0% | – | -2,260.7% | +283.2% | – | -4.8% | -461.7% | -84.7% | +542.2% | +404.3% | -41.2% | -96.2% | +1,675.1% | +336.9% | -69.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +143.1% | +306.1% | +316.8% | -99.7% | -225.7% | -30.8% | -87.5% | – | +274.9% | -95.6% | -54.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +9.3% | +4.9% | -5.1% | +1.7% | -9.1% | +5.4% | +1,058.3% | – | +0.0% | +0.0% | +0.0% | +56.8% | -148.8% | |
| – | -95.4% | – | +140.8% | -3.1% | +56.9% | +1,105.0% | +551.6% | +110.1% | +0.7% | -25.4% | +3.5% | -59.9% | +86.2% | -48.3% | +73.0% | +311.3% | +318.4% | -99.8% | +18,876.9% | -78.1% | +397.3% | +10.7% | +288.6% | -95.6% | +476.6% | +288.2% | +244.0% | -91.5% | |
| – | -212.2% | – | – | -192.0% | – | +7,338.5% | +431.1% | +93.3% | -60.1% | -170.2% | – | – | – | -86.3% | -725.6% | – | +620.6% | -145.2% | – | -1,557.8% | – | +3,520.1% | -140.8% | – | -287.1% | – | -384.3% | – | |
| – | -98.8% | -62,989.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -166.9% | – | -227.9% | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.